Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06827613 |
| Title | A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors (START-002) |
| Acronym | START-002 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Marengo Therapeutics, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| USC Norris Comprehensive Cancer Center | RECRUITING | Los Angeles | California | 90033 | United States | Details |
| UCLA Health | RECRUITING | Los Angeles | California | 90095 | United States | Details |
| Massachusetts General Hospital Cancer Center | RECRUITING | Boston | Massachusetts | 02114 | United States | Details |
| Ohio State University Comprehensive Cancer Center | RECRUITING | Columbus | Ohio | 43212 | United States | Details |
| Sarah Cannon Research Institute | RECRUITING | Nashville | Tennessee | 37203 | United States | Details |
| UT Health San Antonio MD Anderson Cancer Center | RECRUITING | San Antonio | Texas | 78229 | United States | Details |
| BC Cancer | RECRUITING | Vancouver | British Columbia | V5Z 1K1 | Canada | Details |
| Princess Margaret Cancer Centre | RECRUITING | Toronto | Ontario | M5G 2C4 | Canada | Details |